CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Read On .......

Unlocking Drug Delivery to the Brain: Phase 3 Pivotal Trial Uses Ultrasound to Break Through the Blood-Brain Barrier | By: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera

May 1, 2025

Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues neuroscience: Despite all the advances in drug discovery over the past decades, the biggest roadblock to treating brain cancers and other neurological diseases and disorders remains the brain’s own protective shield, the blood-brain barrier. Read on.

Lipoma Removal: Procedure, Recovery And Aftercare Tips For Patients

April 30, 2025

Lipomas are benign tumors that develop from fatty tissue. Although they are usually harmless, lipomas can cause discomfort or be unsightly, leading some patients to

8 Reasons To Consider Disability Support Work

April 30, 2025

Everyone had different aspirations while growing up as to careers they’d like to pursue. However, these job preferences, over time, do change because you might

Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider

April 30, 2025

This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of their customers.

Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer

April 30, 2025

With more than two decades of finance and accounting expertise, Dalen brings extensive experience in scaling private and public companies to his new role.

ZEISS Launches AI-Driven Research Data Platform for Eye Care

April 30, 2025

“The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements,” says Euan S. Thomson, Ph.D., Head of the Digital Business Unit for ZEISS Medical Technology. “The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools.”

XingImaging Unveils NX PET Camera to Advance Parkinson’s Disease Research

April 30, 2025

The **NX PET Camera** offers cutting-edge imaging capabilities, providing researchers with unparalleled precision in detecting and tracking neurodegenerative biomarkers.

Artificial Intelligence Tools Make Education Materials More Patient Friendly

April 30, 2025

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.